QinetiQ Group PLC Logo

QinetiQ Group PLC

Global defence & security firm providing tech solutions, test & evaluation for government clients.

QQ | IL

Overview

Corporate Details

ISIN(s):
GB00B0WMWD03 (+1 more)
LEI:
213800S8OBDOZMCMUW34
Country:
United Kingdom
Address:
CODY TECHNOLOGY PARK, GU14 0LX FARNBOROUGH
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

QinetiQ Group PLC is an integrated global defence and security company focused on mission-led innovation. It operates primarily in the defence, security, and critical national infrastructure markets, providing science and technology-based products and solutions. The company's core activities include managing and operating extensive test and evaluation capabilities for air, land, and sea systems. Key offerings encompass uncrewed aerial targets for live-fire training, systems engineering, survivability solutions, and advisory services. QinetiQ collaborates closely with government clients, including the UK's Ministry of Defence and the U.S. Army, through long-term partnerships to deliver mission-critical capabilities and support.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-08 08:15
Transaction in Own Shares
English 18.3 KB
2025-12-05 08:15
Transaction in Own Shares
English 18.7 KB
2025-12-04 08:25
Transaction in Own Shares
English 18.3 KB
2025-12-03 08:10
Transaction in Own Shares
English 18.3 KB
2025-12-02 08:10
Transaction in Own Shares
English 18.3 KB
2025-12-01 08:15
Transaction in Own Shares
English 18.3 KB
2025-11-28 16:55
Total Voting Rights
English 6.7 KB
2025-11-28 08:15
Transaction in Own Shares
English 18.7 KB
2025-11-27 08:15
Transaction in Own Shares
English 18.7 KB
2025-11-26 08:15
Transaction in Own Shares
English 18.8 KB
2025-11-25 11:20
Holding(s) in Company
English 21.0 KB
2025-11-25 08:15
Transaction in Own Shares
English 18.3 KB
2025-11-24 08:10
Transaction in Own Shares
English 18.8 KB
2025-11-21 08:15
Transaction in Own Shares
English 18.4 KB
2025-11-20 08:10
Transaction in Own Shares
English 18.8 KB

Automate Your Workflow. Get a real-time feed of all QinetiQ Group PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for QinetiQ Group PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for QinetiQ Group PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG

Talk to a Data Expert

Have a question? We'll get back to you promptly.